| Dear Voornaam,
Welcome to your weekly Cancer Research UK Research Update email.
To round off Childhood Cancer Awareness Month and Blood Cancer Awareness Month, we’re pleased to announce the launch of VIVO Biobank, our new partnership with Blood Cancer UK, creating the largest national resource of biological samples and data from cancers affecting children and young people.
While the incidence of these cancers is low, it can mean researchers face limited access to samples. This collaboration, and the merging of our two existing biobanks – the CCLG Tissue Bank and CellBank – provides a single point of access to the widest collection of childhood cancer samples and data available.
In our latest feature we spoke to Professor Christina Halsey, paediatric oncologist and Head of the School of Cancer Sciences at the University of Glasgow, about how this will open opportunities for collaboration and enable high-quality research to develop new treatments and accelerate progress for patients. |
|
|---|
|
|---|
|
|
October Funding & Research Opportunities |
|
|---|
|
|---|
|
|
November–December Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
CELEBRATING WOMEN ENTREPRENEURS IN ONCOLOGY Do you know an inspiring woman entrepreneur that deserves recognition?
Our Cancer Research Horizons Innovation & Entrepreneurship Awards 2022 are showcasing the outstanding achievements of women entrepreneurs and innovators, at any stage of their career, with our Woman Entrepreneur of the Year category.
We are looking for women who have established or are working to establish a business, or have set up a transformative partnership to accelerate scientific discoveries into treatments, diagnostics or medical devices that benefit cancer patients.
Discover more about our awards and our other categories and nominate yourself or a peer by 28 October for the opportunity to receive sector-wide recognition, and to inspire the next generation of entrepreneurs.
|
|
|---|
|
|---|
|
|
NEW GUIDANCE TO SUPPORT PAEDIATRIC TRIAL COSTING Paediatric studies can face several challenges during set up that lead to additional delays when compared to adult trials – this is mainly due to extended negotiations in costing trials and identifying excess research costs. This has been heightened by pressures resulting from the COVID-19 pandemic.
To help overcome this, the Experimental Cancer Medicine Centres (ECMC) network and the NCRI Neuroblastoma sub-group have developed consensus standard of care guidance for early-phase studies involving children and young people with relapsed neuroblastoma.
These provide a clear definition of minimum standard of care requirements which should mitigate undue negotiations and subsequent delays to trial set-up.
Setting up early-phase clinical trials efficiently is critical to providing patients with the earliest possible access to novel treatments. |
|
|---|
| HAVE YOU BOOKED YOUR PLACE AT OUR LUNG CANCER CONFERENCE? Join us in Manchester on 15–17 November for a must-attend meeting for all researchers interested in lung cancer.
The three-day programme of scientific discussion and debate is curated by Charles Swanton and Caroline Dive, co-leads of the CRUK Lung Cancer Centres of Excellence. Discover new opportunities for collaborative research in cancer cell biology, cutting edge drug discovery and novel approaches to the detection, monitoring and treatment of lung cancer.
Latest speakers to join the line-up include Triparna Sen (Memorial Sloan Kettering Cancer Center), Billy Boyle (Owlstone Medical) and Chris Abbosh (AstraZeneca). |
|
|---|
|
|---|
|
|
JOIN US FOR OUR FIRST BLACK IN CANCER CONFERENCE There are only two weeks to go until our first ever Black in Cancer Conference, which will bring together scientists, patient advocates and allies from across the globe to spark new collaborations and showcase Black excellence in cancer research and medicine.
Over the past few weeks, we’ve confirmed some more brilliant speakers, including Faith Uwadiae (Wellcome Trust), Jana McHugh (Institute of Cancer Research) and Jason Mellad (Start Codon) – join us in London on 10–11 October to hear from them.
Also, remember – we’ll be offering a full ticket refund to all undergraduates and PhD students. |
|
|---|
|
|---|
|
|
| | | London, UK 10 October 2022 |
|
|---|
|
|---|
| | | Amsterdam, Netherlands 14 October 2022 |
|
|---|
|
|---|
| | | Portland, Oregon, USA 18 October 2022 |
|
|---|
|
|---|
| | | Manchester, UK 15 November 2022 |
|
|---|
|
|---|
| | | East Sussex, UK 04 December 2022 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
